TGFB1 and neoplasm: Interestingly, in a mouse model recapitulating the immune-excluding CD8( +) T phenotype, T-cell penetration, and tumor regression was induced by co-administration of TGFβ-blocking and anti-PD-L1 antibodies, indicating that TGFβ shapes the tumor microenvironment to restrain anti-tumor immunity [155].